Acadia Pharmaceuticals Inc (ACAD)
Stock-Based Compensation
$31.64M
Quarterly · Period ending: · USD
ACAD Stock-Based Compensation
Latest reported$31.64Mperiod ending
Latest reported$31.64Mperiod ending
ACAD Quarterly Stock-Based Comp ($0.00 → $31.64M)
Quarterly stock-based compensation
High-resolution chart · PNG
ACAD stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 31,638,000 | |
| 14,698,000 | |
| 0 | |
| 13,180,000 | |
| 14,340,000 | |
| 11,380,000 | |
| 10,450,000 | |
| 26,164,000 | |
| 15,685,000 | |
| 14,750,000 | |
| 18,023,000 | |
| 18,539,000 | |
| 15,154,000 | |
| 14,705,000 | |
| 14,414,000 | |
| 18,312,000 | |
| 20,512,000 | |
| 14,963,000 | |
| 12,880,000 | |
| 15,546,000 | |
| 22,005,000 | |
| 13,184,000 | |
| 21,195,000 | |
| 21,372,000 | |
| 19,507,000 | |
| 22,348,000 | |
| 19,763,000 | |
| 22,197,000 | |
| 20,422,000 | |
| 19,883,000 | |
| 20,401,000 | |
| 20,169,000 | |
| 20,552,000 | |
| 20,442,000 | |
| 22,019,000 | |
| 19,698,000 | |
| 18,244,000 | |
| 15,571,000 | |
| 15,418,000 | |
| 14,009,000 | |
| 13,883,000 | |
| 11,955,000 | |
| 8,902,000 | |
| 9,265,000 | |
| 7,499,000 | |
| 14,528,000 | |
| 4,645,000 | |
| 3,901,000 | |
| 4,331,000 | |
| 3,162,000 | |
| 2,174,000 | |
| 1,891,000 | |
| 1,064,000 | |
| 582,000 | |
| 551,000 | |
| 488,000 | |
| 478,000 | |
| 413,000 | |
| 408,000 | |
| 401,000 | |
| 414,000 | |
| 375,000 | |
| 336,000 | |
| 393,000 | |
| 373,000 | |
| 481,000 | |
| 332,000 | |
| 611,000 | |
| 616,000 | |
| 575,000 | |
| 2,987,000 | |
| 0 | |
| 0 | |
| 836,000 | |
| 4,295,000 | |
| 0 | |
| 0 | |
| 1,274,000 | |
| 3,378,000 | |
| 0 | |
| 0 | |
| 900,000,000 | |
| 1,307,700,000 | |
| 0 | |
| 0 | |
| 371,200,000 | |
| 2,355,800,000 | |
| 0 | |
| 0 | |
| 0 |